Trust the Evidence

Trust the Evidence

Share this post

Trust the Evidence
Trust the Evidence
Exploring regulatory data sets of the Comirnaty vaccine - 11a

Exploring regulatory data sets of the Comirnaty vaccine - 11a

Defining the effectiveness outcomes that matter

Tom Jefferson's avatar
Carl Heneghan's avatar
Tom Jefferson
and
Carl Heneghan
Jun 04, 2024
∙ Paid
37

Share this post

Trust the Evidence
Trust the Evidence
Exploring regulatory data sets of the Comirnaty vaccine - 11a
6
5
Share

In this post, we will list and define the effectiveness outcomes that matter in the assessment of Comirnaty. In posts 11b and 11 c, we will compare our definitions with those reported in the package inserts (11b) and regulatory documents (11c). 

Share

The outcomes are listed in order of increasing severity- i.e. danger to life and the community (Our previous post-10C) showed no transmission trials, so we have not included any postexposure prophylaxis outcomes).

Exploring regulatory data sets of the Comirnaty vaccine - 10c

Exploring regulatory data sets of the Comirnaty vaccine - 10c

Tom Jefferson and Carl Heneghan
·
May 28, 2024
Read full story

Covid 19 case

A subject with symptoms of influenza-like illness (ILI), such as fever, cough, shortness of breath, and malaise, has a positive PCR laboratory test.

This is defined as a positive viral culture, meaning a positive cytopathogenic effect with a positive polymerase chain reaction (PCR) or, alternatively, a positive PCR on its own with a cycle threshold below 25. A professional takes the nasopharyngeal swab sample within four days of symptoms onset following a protocol to minimise contamination. The PCR assay used has been previ…

Keep reading with a 7-day free trial

Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Carl Heneghan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share